Skip to Content
Merck

AEC101

AEC Staining Kit

liquid

Synonym(s):

ACE substrate kit

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.32
UNSPSC Code:
41116134
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

liquid

Quality Level

usage

sufficient for ≥1,000 tests (150 ml substrate solution)

storage temp.

2-8°C

Application

AEC Staining Kit has been used as a substrate
  • for developing the extravidin peroxidase antibody in cell-seeded matrice sections using histology and immunohistochemistry methods
  • for streptavidin-horseradish peroxidase in peripheral blood mononuclear cells in ex vivo enzyme-linked immunospot (ELISPOT) assay
  • for mouse IgG biotinylated secondary antibody in immunohistostaining of epididymal fat pads

Packaging

Kit contains 3 mL of concentrated acetate buffer, 3-amino-9-ethylcarbazole (AEC) chromogen and hydrogen peroxide in a dropper bottle for easy dispensing. Directions for use with each application are included.

Disclaimer

Stable at least one year at 2-8 °C.


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Carc. 1B - Eye Irrit. 2 - Flam. Liq. 3 - Repr. 1B

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

134.6 °F - closed cup

flash_point_c

57 °C - closed cup



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis
Vincenti D, et al.
Molecular Medicine, 9(3), 105-105 (2003)
Kaiyuan Ni et al.
Chem, 5(7), 1892-1913 (2019-08-07)
Checkpoint blockade immunotherapy (CBI) elicits durable therapeutic responses by blocking T cell inhibitory pathways of tumors with pre-infiltrated T cells and/or high mutational burden to activate antitumor immunity but is ineffective against poorly immunogenic tumors. Immunogenic radiotherapy, photodynamic therapy (PDT)
Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure
Tang T, et al.
Test, 285(7), 4637-4644 (2010)



Global Trade Item Number

SKUGTIN
AEC101-1KT04061838254719